TP53 and neoplasm: Alteration of p53 by various mechanisms is a frequent finding in malignant disease, although the frequency of mutation in the gene varies considerably between tumour types, with a high proportion of mutations in lung cancer, lower gastrointestinal cancers and glial brain tumours, but low reported frequencies in melanoma and sarcomas (Soussi and Wiman, 2007).